knowlabs.co (USBC): יחס שווי שוק להכנסות

The absence of commercial revenue and the threat of a liquidity shortage are putting pressure on USBC Inc. The revenue multiple on this chart captures the market reaction, where the current metric stands at . Prospects are based on the validation of non-invasive glucose measurement and patent protection. However, uncertainty regarding FDA approval timelines and the probability of test failures remain critical risks for investors.

For USBC Inc (USBC), whose prospects depend on the approval of its glucose monitoring technology, the absence of stable sales makes traditional valuation difficult. This price-to-sales ratio reflects the company's market capitalization relative to sales volume, highlighting the speculative nature of the quotes in the absence of real cash flows. The trend of this indicator demonstrates the extent to which the asset's current price is decoupled from the business's fundamental metrics.